Massachusetts is facing a tough time. The state's research future is at risk because of cuts to federal funding. This is not just about money. It is about the progress of science and the hope it brings to many people. Governor Maura Healey visited UMass Chan Medical School. She saw firsthand how fu
Scientists have developed a set of versatile gene delivery systems that can precisely target different types of cells in the human brain and spinal cord. This advancement is a significant leap forward in the field of gene therapy, offering a more accurate and controlled approach to treating neurolog
The life sciences industry is currently in a state of uncertainty. This is due to a recent decision by the federal government to reduce funding for research institutions. The National Institutes of Health announced in early February that it would limit funding for indirect costs to 15%. These costs
Taxpayers might be surprised to learn that a big chunk of the money given to universities for medical research doesn't actually go to finding cures. Instead, it covers what are called "indirect costs. " These costs are so vague that they can pay for things like professor salaries, office parties, an
Some people in Washington wanted to make big changes to science funding. These proposed cuts could lead to fewer jobs and less research in the medical field. It could also hurt some of the most important breakthroughs. A lot of people were not happy about this, including the state
Let's Talk Funding for Science. NIH made a big announcement. They said they are cutting down on money given to universities for things like equipment and maintenance. A scientist gets a grant of 500k a year, the university will get an extra amount for these other costs.
Chris Viehbacher, the CEO of Biogen, had a message for Governor Maura Healey at a recent event hosted by the Associated Industries of Massachusetts. He was worried about the changes happening in Washington and how they might affect his business. Viehbacher pointed out that his company faces lots of
Imagine this: in the 1950s, heart attacks were a scary reality with no clear solutions. People often died suddenly, with little anyone could do. But some visionaries, like Mary Lasker and Senator Lister Hill, saw potential in medical science. They convinced the government to invest heavily in heart
